Thyroid hormone technology - BTG
Alternative Names: T3 hormone technologyLatest Information Update: 21 Aug 2019
At a glance
- Originator BTG
- Class Thyroid hormones
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cardiovascular disorders; Myocardial infarction
Most Recent Events
- 19 Aug 2019 BTG has been acquired by Boston Scientific Corporation
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cardiovascular-disorders in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Myocardial-infarction in USA (IV)